AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (June 17, 2008). doi:10.1152/ajpendo.00762.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/2/E446    most recent
00762.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karpac, J.
Right arrow Articles by Hochgeschwender, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karpac, J.
Right arrow Articles by Hochgeschwender, U.
Submitted on December 6, 2007
Accepted on June 10, 2008

Failure of adrenal corticosterone production in pro-opiomelanocortin deficient mice results from lack of integrated effects of POMC peptides on multiple factors

Jason Karpac1, Katarzyna Anna Czyzewska1, Andras Kern2, Richard Steve Brush3, Robert Eugene Anderson3, and Ute Hochgeschwender1*

1 MCDB, OMRF, Oklahoma City, Oklahoma, United States
2 Oklahoma City, Oklahoma, United States; MCDB, OMRF, Oklahoma City, Oklahoma, United States
3 Dean A. McGee Eye Institute, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

* To whom correspondence should be addressed. E-mail: ute{at}neuro.duke.edu.

Production of corticosteroids from the adrenal gland is a multi-step process in which corticosterone is enzymatically processed from its precursor cholesterol. The main hormone regulating the production of corticosterone is the pro-opiomelanocortin (POMC)-derived adrenocorticotropin (ACTH). Adrenals of POMC-deficient (POMC-/-) mice do not produce corticosterone, neither at basal levels nor in response to acute stimulation with ACTH. However, pharmacological amounts of ACTH delivered continuously elicit corticosterone production over time. To define the relative effects of ACTH on individual factors involved in corticosterone production, parameters of adrenal cholesterol metabolism and steroidogenesis were examined in POMC-/- mice in comparison to wildtype and ACTH-treated mutant mice. POMC-/- adrenals lack cholesterol esters (CE); adrenal CE is restored with ACTH treatment. However, discontinuation of ACTH treatment stops corticosterone production despite presence of adrenal CE. Failure of corticosterone production by POMC-/- adrenals occurs despite the constitutive presence of transcripts of genes required for cholesterol metabolism and steroidogenesis. Levels of key proteins involved in selective-cholesterol uptake and steroidogenesis were attenuated; ACTH treatment increased these protein levels, most significantly those of the receptor responsible for selective uptake of CE, scavenger receptor class B, type I (SR-BI). Our studies reveal that failure of corticosterone production of POMC-/- adrenal glands and its pharmacological reconstitution by ACTH are not mediated by any one individual protein, but rather as an integrated effect on multiple factors from import of the substrate cholesterol to its conversion to corticosterone.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.